Nanoveu Ltd. (AU:NVU)
ASX:NVU
Want to see AU:NVU full AI Analyst Report?
Top Page
Nanoveu Ltd.
(Sydney:NVU)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.05
▼(-41.11% Downside)
Action:Upgraded
Date:06/17/26
The score is primarily constrained by weak financial performance (deep losses and ongoing cash burn) and bearish technical conditions (below major moving averages with negative MACD). Valuation does not provide support due to loss-making earnings and no dividend yield data.
Positive Factors
Proprietary coating technology
Nanoveu’s core focus on proprietary protective and functional nanocoatings represents a durable technical moat. Proprietary formulations that can be applied to many device surfaces support differentiated product offerings and enable licensing or OEM integration, underpinning long-term commercial optionality.
Negative Factors
Persistent negative cash flow
Operating and free cash flow have been negative every year, with a larger burn in 2025. Persistent cash consumption forces dependence on external financing, constrains reinvestment into commercialization, and increases dilution or refinancing risk if revenue does not sustainably scale.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary coating technology
Nanoveu’s core focus on proprietary protective and functional nanocoatings represents a durable technical moat. Proprietary formulations that can be applied to many device surfaces support differentiated product offerings and enable licensing or OEM integration, underpinning long-term commercial optionality.
Read all positive factors
Nanoveu Ltd. (NVU) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$61.59M
Dividend YieldN/A
Average Volume (3M)9.28M
Price to Earnings (P/E)―
Beta (1Y)2.73
Revenue GrowthN/A
EPS GrowthN/A
CountryAU
Employees9
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,080,451,200
10 Day Avg. Volume7,199,231
30 Day Avg. Volume9,283,654
Financial Highlights & Ratios
PEG Ratio-0.19
Price to Book (P/B)5.64
Price to Sales (P/S)233.13
P/FCF Ratio-11.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nanoveu Ltd. Business Overview & Revenue Model
Company Description
Nanoveu Limited, an Australian technology company founded in 2018 and based in Subiaco, focuses on inventing and globally marketing nanotechnology-based solutions for consumer electronics. Its current offerings include Nanoshield, an antiviral pro...
How the Company Makes Money
Nanoveu makes money by commercializing its proprietary coating and film technologies through business-to-business arrangements, including supplying products and/or licensing its technology to partners that manufacture, distribute, or apply these c...
Nanoveu Ltd. Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
46
Neutral
Cash Flow
18
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 297.58K | 6.87K | 102.54K | 159.51K | 781.21K |
| Gross Profit | -2.23M | 10.53K | 25.27K | 72.37K | 386.56K |
| EBITDA | -7.45M | -2.73M | -1.98M | -2.45M | -1.97M |
| Net Income | -7.42M | -2.85M | -2.16M | -2.67M | -2.32M |
Balance Sheet | |||||
| Total Assets | 13.55M | 1.32M | 513.00K | 427.33K | 2.75M |
| Cash, Cash Equivalents and Short-Term Investments | 1.81M | 498.30K | 73.07K | 248.14K | 2.01M |
| Total Debt | 341.96K | 126.33K | 225.26K | 300.00K | 986.68K |
| Total Liabilities | 1.46M | 983.58K | 622.40K | 700.75K | 1.17M |
| Stockholders Equity | 12.31M | 374.94K | -109.41K | -273.41K | 1.58M |
Cash Flow | |||||
| Free Cash Flow | -5.92M | -2.10M | -2.01M | -2.82M | -2.04M |
| Operating Cash Flow | -5.85M | -2.10M | -2.01M | -2.82M | -2.04M |
| Investing Cash Flow | -287.31K | -258.66K | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 7.44M | 2.53M | 1.83M | 142.12K | 2.91M |
Nanoveu Ltd. Technical Analysis
Neutral
0.09
Price Trends
0.06
Negative
0.06
Negative
0.08
Negative
Market Momentum
>-0.01
Negative
60.77
Neutral
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NVU, the sentiment is Neutral. The current price of 0.09 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.06, and above the 200-day MA of 0.08, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 60.77 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:NVU.
Nanoveu Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | AU$30.75M | -97.99 | -2.31% | ― | 2.98% | 93.55% | |
48 Neutral | AU$24.70M | -5.47 | -27.05% | ― | 4.41% | 19.30% | |
46 Neutral | AU$24.58M | -5.73 | -153.09% | ― | 6.66% | ― | |
43 Neutral | AU$14.26M | -0.15 | -562.56% | ― | ― | ― | |
42 Neutral | AU$61.59M | -6.32 | -86.31% | ― | ― | ― | |
41 Neutral | AU$14.31M | -6.67 | 46.05% | ― | -0.91% | 1.85% |
* Technology Sector Average
AU:NVU
Nanoveu Ltd.
0.06
0.02
46.15%
AU:1TT
Wooboard Technologies Limited
0.01
0.00
0.00%
AU:VIG
Victor Group Holdings Ltd
0.04
-0.04
-46.75%
AU:AMX
Aerometrex Ltd.
0.26
0.05
23.81%
AU:XF1
Xref Ltd
0.07
-0.10
-59.38%
AU:ICE
iCetana Ltd.
0.04
-0.02
-30.19%
Nanoveu Ltd. Corporate Events
Nanoveu Showcases Sub-1mW Bone-Conduction Voice Control for Next-Gen Hearables
Jun 16, 2026
Nanoveu has unveiled a breakthrough in always-on edge AI sensing, demonstrating real-time keyword spotting on its ECS-DoT chip using bone-conduction vibration from the jawbone instead of microphones, operating at under 1 milliwatt. By capturing sp...
Nanoveu Issues 5 Million Unquoted Performance Rights
May 28, 2026
Nanoveu Limited has notified the market of the issue of 5,000,000 unquoted performance rights, recorded under the ASX security code NVUAI. The new securities, which are not intended to be quoted on the ASX, were issued on 28 May 2026 as part of pr...
Nanoveu Shares Suspended as Company Prepares Drone Tech Acquisition Announcement
May 13, 2026
Nanoveu Limited has requested and been granted a voluntary suspension of its shares on the ASX under Listing Rule 17.2, following the expiry of a prior trading halt. The suspension is to remain in place until either the company releases a pending ...
Nanoveu Seeks Trading Halt Ahead of Drone Technology Acquisition
May 10, 2026
Nanoveu Limited has requested a trading halt on its securities on the ASX as it prepares to announce a proposed acquisition aimed at expanding its drone technology capabilities. The halt will remain in place until either the announcement is releas...
Nanoveu advances 16nm edge AI chip as capital raise and new applications broaden market reach
Apr 29, 2026
Nanoveu reported a pivotal March quarter as its EMASS subsidiary completed tape-out of a next-generation 16nm ECS-DoT edge AI chip and moved it into fabrication at TSMC, while continuing to market its existing 22nm platform as a near-term commerci...
Nanoveu sets in-person May 29 AGM and shifts to digital meeting materials
Apr 28, 2026
Nanoveu Limited has called its Annual General Meeting for 11:00 a.m. AWST on 29 May 2026 at The Boorloo Meeting Room, 108 St Georges Terrace in Perth, with all resolutions to be decided by poll and shareholder eligibility determined as at 5:00 p.m...
Nanoveu sets 2026 AGM date and opens nominations for board candidates
Apr 9, 2026
Nanoveu Limited has scheduled its 2026 Annual General Meeting for 29 May 2026, with details to be provided in a forthcoming notice of meeting to shareholders. The company has set 17 April 2026 as the deadline for written nominations from individua...
Nanoveu Showcases EMASS Strategy at Pitt Street Semiconductor Conference
Mar 24, 2026
Nanoveu Limited announced its participation in the Pitt Street Research Semiconductor Conference 2026, where Director and EMASS founder Dr Mohamed Sabry is outlining the company’s strategy for advancing its EMASS semiconductor business. The ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.